Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José M Mostaza

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Medicina Clinica|June 19, 2009
[HDL-cholesterol: from risk factor to therapeutic target]Carlos Lahoz, José M Mostaza
Revista Espanola De Cardiologia|March 7, 2007
[Atherosclerosis as a systemic disease]Carlos Lahoz, José M Mostaza
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[Lipid-lowering drugs and PCSK9]Jesús Millán Núñez-Cortés, José M Mostaza Prieto
Geriatrics & Gerontology International|December 19, 2018
Prevalence of atrial fibrillation and associated anticoagulant therapy in the nonagenarian population of the Community of Madrid, SpainCarlos Lahoz, Juan Cardenas, Miguel Á Salinero-Fort, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 18, 2013
[Achievement of low-density lipoprotein cholesterol therapeutic goal in lipid and vascular risk units of the Spanish Arteriosclerosis Society]Juan Pedro-Botet, José M Mostaza, Xavier Pintó, et al.
Revista Espanola De Cardiologia (English Ed.)|June 5, 2012
Utilization of evidence-based cardiovascular therapies and achievement of therapeutic goals in patients with peripheral artery diseaseJosé M Mostaza, Enrique Puras, Mariano Blasco, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 15, 2013
Differences in the ankle-brachial index in the general population after 4 years of follow-upCarlos Lahoz, Teresa Garcia-Fernandez, Maria Barrionuevo, et al.
Medicina Clinica|April 26, 2005
[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function]José M Mostaza, Ignacio Vicente, Manuel Taboada, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 17, 2015
[Cancer and cardiovascular disease]Carlos Lahoz, Pedro Valdivielso, María Teresa González-Alegre, et al.
Revista Espanola De Cardiologia (English Ed.)|June 26, 2012
Prevalence and clinical characteristics of peripheral arterial disease in the study population HermexFrancisco J Félix-Redondo, Daniel Fernández-Bergés, María Grau, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Medicina Clinica|June 19, 2009
[HDL-cholesterol: from risk factor to therapeutic target]Carlos Lahoz, José M Mostaza
Revista Espanola De Cardiologia|March 7, 2007
[Atherosclerosis as a systemic disease]Carlos Lahoz, José M Mostaza
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 28, 2016
[Lipid-lowering drugs and PCSK9]Jesús Millán Núñez-Cortés, José M Mostaza Prieto
Geriatrics & Gerontology International|December 19, 2018
Prevalence of atrial fibrillation and associated anticoagulant therapy in the nonagenarian population of the Community of Madrid, SpainCarlos Lahoz, Juan Cardenas, Miguel Á Salinero-Fort, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 18, 2013
[Achievement of low-density lipoprotein cholesterol therapeutic goal in lipid and vascular risk units of the Spanish Arteriosclerosis Society]Juan Pedro-Botet, José M Mostaza, Xavier Pintó, et al.
Revista Espanola De Cardiologia (English Ed.)|June 5, 2012
Utilization of evidence-based cardiovascular therapies and achievement of therapeutic goals in patients with peripheral artery diseaseJosé M Mostaza, Enrique Puras, Mariano Blasco, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|March 15, 2013
Differences in the ankle-brachial index in the general population after 4 years of follow-upCarlos Lahoz, Teresa Garcia-Fernandez, Maria Barrionuevo, et al.
Medicina Clinica|April 26, 2005
[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function]José M Mostaza, Ignacio Vicente, Manuel Taboada, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 17, 2015
[Cancer and cardiovascular disease]Carlos Lahoz, Pedro Valdivielso, María Teresa González-Alegre, et al.
Revista Espanola De Cardiologia (English Ed.)|June 26, 2012
Prevalence and clinical characteristics of peripheral arterial disease in the study population HermexFrancisco J Félix-Redondo, Daniel Fernández-Bergés, María Grau, et al.
Pageof 3